Biome Australia Ltd (AU:BIO) has released an update.
Biome Australia Ltd has reported a landmark quarter, announcing its first positive quarterly EBITDA and underlying operating cash flow in Q3 FY24, alongside a robust 74% increase in sales revenue to $3.2 million compared to the previous corresponding period. Additionally, the company has seen a significant 61.4% rise in same-store pharmacy sales and ended the quarter with an improved cash position.
For further insights into AU:BIO stock, check out TipRanks’ Stock Analysis page.